Valentine Capital Asset Management’s Biogen BIIB Stock Holding History

Valentine Capital Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.22M	Buy	+3,973	New	+$1.14M	1.36%	27

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Valentine Capital Asset Management's BIIB Position: Q4 2015 in Review

Valentine Capital Asset Management opened a new position in Biogen (BIIB) in Q4 2015: 3,973 shares worth $1.22M. The stake represents 1.36% of the portfolio and ranks #27 among its holdings.

969 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

Valentine Capital Asset Management held 3,973 shares of Biogen worth $1.22M as of Q4 2015.
Biogen was a new Valentine Capital Asset Management position in Q4 2015.
Biogen made up 1.36% of Valentine Capital Asset Management's portfolio in Q4 2015, its #27 holding.
969 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.